In vitro and in vivo suppression of GJB2 expression by RNA interference. - Wikidata - wikimedia - TriplyDB

In vitro and in vivo suppression of GJB2 expression by RNA interference.

In vitro and in vivo suppression of GJB2 expression by RNA interference.

http://www.wikidata.org/entity/Q50473508

about

Gene therapy for the inner ear Gene therapy for human hearing loss: challenges and promises Inner ear symptoms and disease: pathophysiological understanding and therapeutic options Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6 Regeneration of mammalian cochlear and vestibular hair cells through Hes1/Hes5 modulation with siRNA Gene therapy for deafness.Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice.The design and screening of drugs to prevent acquired sensorineural hearing loss Regeneration of Hair Cells: Making Sense of All the Noise.Drug delivery for treatment of inner ear disease: current state of knowledge Inner ear drug delivery for auditory applications.Early investigational drugs for hearing loss.Hearing loss in syndromic craniosynostoses: introduction and consideration of mechanisms Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange-Nielsen deafness syndrome.The therapeutic potential of RNA interference.Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.siRNA targeting Hes5 augments hair cell regeneration in aminoglycoside-damaged mouse utricle.Drug delivery systems for the treatment of sensorineural hearing loss.RNA Interference Prevents Autosomal-Dominant Hearing Loss.Therapeutic regulation of gene expression in the inner ear using RNA interference.Connexin-26 mutations in deafness and skin disease.Mechanisms linking connexin mutations to human diseases.New treatment options for hearing loss.Identification of Adeno-Associated Viral Vectors That Target Neonatal and Adult Mammalian Inner Ear Cell Subtypes.Emerging Gene Therapies for Genetic Hearing Loss.Bpifcl modulates kiss2 expression under the influence of 11-ketotestosterone in female zebrafish.Have you heard? Viral-mediated gene therapy restores hearing.Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locus.Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness.Short interfering RNA against Bax attenuates TNFα-induced ototoxicity in rat organ of Corti explants.An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.[Gene therapy and stem cells for the inner ear: a review].Outlook and future of inner ear therapy

P2860

Q26851920-DE2E5755-BBB9-4EC7-9457-AA0DABDE06BD Q26996322-17DDA1D1-8C67-43C8-9402-49F676CA9353 Q26997318-D8DAAB1D-3EB1-4D53-AEB8-DA8ED4D9627E Q28576301-9AA511CF-C8A3-493E-9225-427BD9DF2B1F Q30429653-6EA10C47-0EF5-43DC-9319-59D934105AE1 Q30434063-BE12E36F-7B94-497C-9878-3EB86E680A50 Q30435650-1E730631-009B-4D88-B2B4-4425C3649CAA Q30465748-7E820EC2-78BA-4B30-959E-A0E64D122E78 Q30467210-81C69762-D4C7-4742-B319-AC6E01D2F8B3 Q30476020-6C9B1A86-6F89-4031-A976-19C45EBC82CF Q30484636-5D7FBD58-1BA6-4C8E-A4D0-FA9420D3026B Q33847686-AD5BD4E7-1349-40D1-9841-F4A93FE8450E Q34041534-9D5186C4-B0D1-4628-8B33-4E36712AF4B8 Q36000818-C71849E9-BB2C-46E5-82AA-062604C39B88 Q36237868-5E13466A-2DE6-4B47-BEE6-1D8031B6396B Q36631534-B185411D-06BF-4F87-96AB-EBC6CE403404 Q36740280-BA382E5D-2875-4C18-B81E-8A218E9C6BA0 Q36799313-E136D3BA-8A99-48C5-A760-94E66BE27083 Q37004981-F3752EFD-11A6-4098-85FF-E05EE839DE2F Q37507085-2344BD18-A9DC-458D-8DF8-3CFEF7986B1B Q37638797-98C11289-051F-4AF2-A398-7B86EDBA0137 Q38268356-68256B5E-E5DE-4DDE-8E3E-4DBEF2B8B7A7 Q38384722-2269328B-1443-49D4-8D5E-5645FF02980F Q38848707-3951BDC0-9C6A-464D-B2BB-47DC7585079D Q40080564-271AC948-0592-444F-A7C7-DE2D25348AEC Q41366862-2DB0762B-38A2-43DC-B0EC-0C0D5D5A17FD Q41591265-B38B638D-E004-400C-977C-1A71712B86F8 Q42137072-965645EC-6150-4FF5-A789-39552C1F8BB4 Q42153064-E4158F8F-2DF8-43C9-9E65-E985CA972C1F Q42520601-BB2488F5-1277-42B8-A5ED-F64994ED92FE Q45887696-AED66B5F-C5D8-4F0C-B468-82A507C8AB64 Q48106045-CF0DAAAA-7342-4A3D-9700-B4237EEDE678 Q50426000-18911A76-8D89-4EB5-B90B-5AA8B77A0C71 Q57139394-8F24208E-A3C5-472C-8819-55E7DE49FE92

P2860

In vitro and in vivo suppression of GJB2 expression by RNA interference.

http://www.wikidata.org/entity/Q50473508

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

In vitro and in vivo suppression of GJB2 expression by RNA interference.

@en

In vitro and in vivo suppression of GJB2 expression by RNA interference.

@nl

type

label

In vitro and in vivo suppression of GJB2 expression by RNA interference.

@en

In vitro and in vivo suppression of GJB2 expression by RNA interference.

@nl

prefLabel

In vitro and in vivo suppression of GJB2 expression by RNA interference.

@en

In vitro and in vivo suppression of GJB2 expression by RNA interference.

@nl

P1433

Q50473508-00603887-6474-4181-A70B-BAAE93A4EBCA

P1476

Q50473508-9039FD4C-4BEB-4606-B58C-FA787C1F7F9A

P2093

Q50473508-04CCEF77-CE54-4F25-A299-436197903D46

Q50473508-47057B03-3BD0-4C50-BE2C-07364FA20F4F

Q50473508-724C9986-B76B-44C3-9792-221CE4BA8AA3

P2860

Q50473508-0A62C6A3-52DD-4C13-95BA-6E9B555C5A84

Q50473508-10C81D2B-0947-4CFA-A642-0743EC7C3B04

Q50473508-11E0A1E9-8801-43BC-B4FE-DFBF1BBF1434

Q50473508-15560342-CBEC-4D21-AE15-1EE98A065CD8

Q50473508-24B2B192-AB46-496F-9C1D-824020865A0A

Q50473508-2C4D0412-7344-4F67-B0D0-66E7D1ECB60A

Q50473508-2D8D68CD-9E67-4274-9970-C01928022476

Q50473508-2DC40018-48FB-420B-B4F5-843815B90F8B

Q50473508-2F4E4FF9-D13B-4AF9-8FFD-45AE7F02EE6B

Q50473508-33012C43-F4B8-4CC1-84B0-E9788BE97B29

P304

Q50473508-821A7878-FDC7-4852-B133-6DD65AE8641C

P31

Q50473508-418BC22D-6277-44FB-A04D-99A3A1BB12FE

P356

Q50473508-DE2D7B73-79C7-4409-80E3-428BBF4FF1E9

P433

Q50473508-7A4436AE-B278-4FD7-8AD9-909F419034F0

P478

Q50473508-45A13E98-3A31-423D-AB81-7EE0B0B5AEBB

P50

Q50473508-ABB06E95-77D8-4C4F-907D-866A772D7EF3

P577

Q50473508-C6D5924B-DB8E-4D8D-A128-4A4E83D65E08

P5875

Q50473508-1D1FF766-2173-4299-9C15-B847F161A865

P698

Q50473508-811F6BC5-1788-4938-BD34-41E6E16F2E59

P356

P1433

Human Molecular Genetics

P1476

In vitro and in vivo suppression of GJB2 expression by RNA interference

@en

P2093

Kazunori Nishizaki

http://www.w3.org/2001/XMLSchema#string

Kunihiro Fukushima

http://www.w3.org/2001/XMLSchema#string

Yukihide Maeda

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13)

Ribonuclease activity and RNA binding of recombinant human Dicer

Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference

Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP

RNA interference is mediated by 21- and 22-nucleotide RNAs

Role for a bidentate ribonuclease in the initiation step of RNA interference

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Connexin 26 mutations in hereditary non-syndromic sensorineural deafness

Connexin-26 mutations in sporadic and inherited sensorineural deafness

Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness

P304

1641-1650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDI172

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Richard J Smith

P577

2005-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7879947

http://www.w3.org/2001/XMLSchema#string

P698

15857852

http://www.w3.org/2001/XMLSchema#string